NY-IBERDROLA
24.9.2018 23:14:12 CEST | Business Wire | Press release
Today, Iberdrola, one of the world’s largest utilities and the leading renewable energy producer, is pleased to announce that the Company has been recognized as Global Compact LEAD for demonstrating its ongoing commitment to the United Nations Global Compact and its Ten Principles for responsible business.
Announced at UN Headquarters in New York during the UN Global Compact Leaders Summit 2018, Iberdrola was identified as being among the highest-engaged participants of the world’s largest corporate sustainability initiative.
Lise Kingo, CEO and Executive Director of the UN Global Compact, said, “LEAD companies represent the highest level of engagement with the UN Global Compact. Achieving the Sustainable Development Goals and creating the world we want will not happen without bold action from the responsible business community. We need companies of all sizes — like the ones recognized today — to improve their performance, no matter where they are on their sustainability journey.”
“Since the Paris Summit took place in 2015, three out of the five most relevant global risks in terms of likelihood and impact are climate-related, according to a survey by the World Economic Forum. None of these risks were among the top five just 10 years ago. Governments, businesses and civil society, we all have the moral obligation to fight climate change and transform words into deeds,” said Ignacio Galán, Chairman and CEO of Iberdrola, speaking today at the United Nations.
“Climate action has been part of Iberdrola’s strategy and business decisions for the last 20 years,” added Mr. Galán. “Since 2001, we have invested 100 billion dollars in renewable energies, smart grids and efficient pumped hydro storage to bring down our emissions. Our story proves that fighting climate change creates business opportunities while benefiting both our shareholders and society at large.”
Iberdrola is present in numerous countries and supplies energy to over 100 million people. With over $130 billion in assets across the globe, it is one of the companies with the lowest emissions and an international benchmark for its contribution to the sustainability of the planet. The Company has consolidated as one of the top energy companies in the US where it operates as Avangrid, Inc. (NYSE: AGR), a leading, sustainable energy company with $31 billion in assets and operations in 24 U.S. states.
To be eligible for LEAD recognition, companies must:
1. Be a participant in at least two Action Platforms, to demonstrate the company’s engagement with the UN Global Compact and commitment to defining and fostering leadership practices in line with the Ten Principles and Global Goals; and
2. Submit or commit to submitting an Advanced Communication on Progress — an annual sustainability report detailing progress on implementing the Ten Principles — within the same calendar year.
Since joining the UN Global Compact in 2002, Iberdrola has been proud to be part of a global movement of sustainable companies and stakeholders. By integrating a principles-based approach to sustainability, Iberdrola is taking shared responsibility for achieving a better world.
Iberdrola has demonstrated its commitment to the UN Global Compact by participating in Action Platforms on Breakthrough Innovation, Reporting on the SDGs, Financial Innovation for the SDGs, Pathways to Low-Carbon & Resilient Development. You can view Iberdrola’s Communication on Progress (CoP) and other activities and engagements on our Participant profile on the UN Global Compact website here https://www.unglobalcompact.org/what-is-gc/participants/5027-Iberdrola-S-A- .
About Iberdrola
Iberdrola is present in numerous countries and supplies energy to over 100 million people mainly in Spain, the United Kingdom (Scottish Power), USA (AVANGRID), Brazil (Neoenergia) and Mexico. The group provides direct and indirect jobs to over 400.000 people across the globe and has assets in excess of €110 billion. In 2017, it posted revenues of €31.26 billion and a net profit of €2.8 billion.
Iberdrola leads the energy transition towards a sustainable model through investments in renewable energy, smart grids, efficient energy storage and digital transformation, offering the most advanced products and services to its customers. Thanks to its commitment to clean energy, Iberdrola is one of the companies with the lowest emissions and an international benchmark for its contribution to the fight against climate change and for the sustainability of the planet. Iberdrola is listed on numerous international sustainability indices, among them the Dow Jones Sustainability Index and FTSE4Good, and it is considered one of the most sustainable electricity utilities in the world.
About the United Nations Global Compact
The United Nations Global Compact is a call to companies everywhere to align their operations and strategies with ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption, and to take action in support of UN goals and issues embodied in the Sustainable Development Goals. The UN Global Compact is a leadership platform for the development, implementation and disclosure of responsible corporate practices. Launched in 2000, it is the largest corporate sustainability initiative in the world, with more than 9,000 companies and 3,000 non-business signatories based in over 160 countries, and nearly 70 Local Networks.
For more information, follow @globalcompact and visit www.unglobalcompact.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20180924006003/en/
Contact:
For Iberdrola Media Eduardo González, +34 638 146 175 Corporate Communications egonzalezf@iberdrola.es
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
